• Thu Jun 4 2026
Logo
Health Insurance Board calls for responsible use of insurance services

Kathmandu, Jan 27: The Health Insurance Board has appealed to both service recipients and service providers to act responsibly to ensure the effectiveness and sustainability of the Health Insurance Program. Issuing an appeal on Tuesday, the Board urged insured citizens to use health services judiciously, refrain from misusing insurance facilities,

FSP treatment to be availed from 377 hospitals: Health Insurance…

Those over 9.3 million insured individuals under the government's health insurance scheme can now avail First Service Point (FSP) treatment

11 candidates shortlisted for Executive Director of Health Insurance Board

The recommendation committee has approved and shortlisted the names of 11 candidates for the Executive Director of the Health Insurance

Agro ambulance service in the offing at local level

Balewa, Jan 18: Jaimini Municipality is preparing to operate agriculture ambulance service so as to bring the agro products of

Bhaktapur Cancer Hospital all set with its new Hospital App

Kathmandu, Aug 17 : Bhaktapur Cancer Hospital is a cancer hospital located in Bhaktapur, Nepal, run by the Government of

RoK provides grant assistance of Fully Automated Biochemistry Analyzers to…

The Embassy of the Republic of Korea (RoK) has donated Fully Automated Biochemistry Analyzers, valued at USD 402,500, to Nepal.

Government providing Rs 10,000 to COVID-affected families

KATHMANDU: The government has prepared a work procedure for providing monetary assistance to the families of those rendered jobless due

poultry
Bird flu detected in Kathmandu

KATHMANDU: Bird flu has been detected in a flock of Turkey ducks at Sanglekhola Fatung in Tarakeswor municiplaity-7 of Kathmandu.

Nepal Airlines to accept govt. PCR report only

Kathmandu: National flag carrier Nepal Airlines Corporation (NAC) has announced that it would accept the PCR test report only from

2nd study testing a COVID-19 antibody drug has a setback

Washington DC, Oct 30 (AP) — For the second time, a study testing an experimental antibody drug for COVID-19 has